drugset / Trial / NCT04612413
A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
A Phase 2, Multi-Center, Randomized, Placebo-Controlled, Dose-Finding Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
Timeline
- Start
- 2020-11-30
- Primary completion
- 2024-01-12
- Completion
- 2024-12-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allocetra-OTS | Cell therapy | 5e+09 cells | Intravenous |
| Subject | Allocetra-OTS | Cell therapy | 1e+10 cells | Intravenous |